LifeStance Health Group, Inc. (LFST)

LifeStance Health Group Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021
Market Capitalization	2,370	2,964	1,857	3,562
Market Cap Growth	-	59.61%	-47.85%	-
Enterprise Value	2,799	3,394	2,225	3,571
PE Ratio	-15.92	-15.92	-8.62	-10.36
PS Ratio	2.24	2.81	2.16	5.34
PB Ratio	1.66	2.08	1.22	2.31
P/FCF Ratio	-51.64	-51.64	-70.18	-41.87
P/OCF Ratio	-175.58	-175.58	35.18	378.12
EV/Sales Ratio	2.65	3.21	2.59	5.35
EV/EBITDA Ratio	-52.26	-52.26	-21.10	-12.90
EV/EBIT Ratio	-18.31	-18.31	-10.46	-10.79
EV/FCF Ratio	-59.12	-59.12	-84.08	-41.98
Debt / Equity Ratio	0.36	0.36	0.31	0.10
Debt / EBITDA Ratio	-7.82	-7.82	-4.52	-0.57
Debt / FCF Ratio	-8.85	-8.85	-18.00	-1.85
Quick Ratio	1.01	1.01	1.19	1.92
Current Ratio	1.11	1.11	1.33	2.28
Asset Turnover	0.49	0.49	0.43	0.36
Interest Coverage	-8.74	-8.74	-10.68	-8.51
Return on Equity (ROE)	-12.70%	-12.70%	-14.10%	-24.60%
Return on Assets (ROA)	-8.60%	-8.60%	-10.70%	-18.70%
Return on Capital (ROIC)	-9.76%	-9.76%	-10.53%	-16.82%
Earnings Yield	-7.86%	-6.28%	-11.61%	-9.66%
FCF Yield	-2.42%	-1.94%	-1.42%	-2.39%
Buyback Yield / Dilution	-3.43%	-3.43%	-8.47%	-
Total Shareholder Return	-3.43%	-3.43%	-8.47%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).